Research led by the Royal Women’s Hospital, Australia, has found that early intratracheal administration of budesonide mixed with surfactant may have little to no effect on improving survival free of bronchopulmonary dysplasia (BPD) in extremely preterm infants.
Steroid and surfactant mix fails to impact bronchopulmonary dysplasia in preterm infants
